Healthy Living After Knee Replacement
Launched by UNIVERSITY OF SOUTH CAROLINA · Jan 12, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Healthy Living After Knee Replacement" is looking at whether a special weight loss program can help adults who have recently had knee replacement surgery. The study aims to see if this program can lead to more weight loss, increased physical activity, less pain, and improved function compared to a standard program for managing chronic diseases. It's important to note that the trial is currently recruiting participants who are overweight or obese and have had knee surgery within the past six months.
To be eligible, participants should have a body mass index (BMI) between 25 and 45, which means they are considered overweight or obese. They must also have access to a computer or smartphone for online monitoring and be able to attend four in-person assessments during the study. Participants will complete assessments that measure their height, weight, physical function, and activity levels. This trial is a great opportunity for those who want to improve their health after knee replacement surgery while contributing to valuable research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Participants must:
- • have a body mass index between 25-45 kg/m2
- • have had a knee replacement (including primary, staged or independent bilateral, or revision) \<6 months prior to baseline assessment
- • have a computer, tablet, or smartphone with active internet access to self-monitor online and/or have a device or computer compatible with Fitbit
- • completion of baseline assessment measures (height, weight, function tests, surveys, ≥4 days valid of activity monitoring, and 1 day of dietary recall)
- • be English-speaking and able to read consent and study materials written in English
- • be willing to attend 4 in-person assessments.
- Exclusion Criteria:
- • have any contraindications to diet or weight loss
- • undergo simultaneous bilateral knee replacement or have a scheduled or anticipated knee replacement for the contralateral knee within the next 18 months
- • have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinal stenosis, fibromyalgia, peripheral vascular disease, stroke)
- • are taking anti-obesity medications
- • are enrolled in a formal weight loss program
- • had or are planning to have bariatric/gastric/lap band surgery
- • are planning to relocate out of the Columbia or Greenville, SC areas in the next 18 months.
About University Of South Carolina
The University of South Carolina (USC) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and education, USC leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical investigations aimed at improving patient outcomes and addressing pressing health challenges. Collaborating with a diverse network of healthcare professionals, researchers, and community partners, USC fosters an environment of discovery and translation, ensuring that findings from clinical trials contribute significantly to the advancement of medical science and evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, South Carolina, United States
Patients applied
Trial Officials
Christine Pellegrini, PhD
Principal Investigator
University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials